Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma
Clinical trial NCT00972933 · COMPLETED
Trial details
- NCT number
- NCT00972933
- Sponsor
- Diwakar Davar
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2013-07-17
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.